Enhancement of perioperative tissue perfusion as a therapeutic strategy for major surgery

O Boyd1, E D Bennett

  • 1Department of Anaesthesia, St. George's Hospital, London, UK.

New Horizons (Baltimore, Md.)
|November 1, 1996
PubMed

Insights

Optimizing cardiac output in surgical patients may reduce deaths from multiple organ dysfunction syndrome (MODS). Early intervention to improve tissue perfusion benefits high-risk patients, potentially lowering mortality and healthcare costs.

Area of Science:

  • Critical Care Medicine
  • Surgical Outcomes
  • Pathophysiology

Background:

  • Multiple organ dysfunction syndrome (MODS) is a leading cause of surgical mortality, often linked to tissue hypoxia and reperfusion injury.
  • Surgical patients, especially those with compromised cardiovascular reserve, are susceptible to tissue hypoxia and hypoperfusion.
  • Existing research suggests a link between poor cardiovascular function and adverse postoperative outcomes.

Purpose of the Study:

  • To investigate the impact of perioperative cardiac output augmentation on outcomes in surgical patients.
  • To determine if early interventions aimed at improving tissue perfusion can reduce mortality and morbidity.
  • To identify patient subgroups who may benefit most from enhanced hemodynamic management.

Main Methods:

  • Review of clinical studies involving perioperative interventions to augment cardiac output in surgical patients.
  • Analysis of outcomes in critically ill patients receiving similar interventions at later stages of illness.
  • Examination of data correlating pre-existing conditions and cardiac function with treatment response.

Main Results:

  • Early perioperative interventions to improve tissue perfusion in surgical patients have shown reductions in mortality and morbidity.
  • Similar interventions in non-surgical critically ill patients, applied later in their illness, did not demonstrate improved outcomes.
  • Surgical patients with significant comorbidities and impaired cardiac function appear to benefit most from improved tissue perfusion strategies.

Conclusions:

  • Prophylactic augmentation of cardiac output and tissue perfusion in the perioperative period is crucial for high-risk surgical patients.
  • These interventions may lead to significant reductions in mortality, morbidity, and potentially healthcare costs.
  • Management of high-risk surgical patients should incorporate monitoring and optimization of cardiac output and tissue perfusion.